Phibro Animal Health Corporation (NASDAQ:PAHC) Receives Average Recommendation of “Hold” from Brokerages

Phibro Animal Health Corporation (NASDAQ:PAHC) has received a consensus rating of “Hold” from the eight research firms that are covering the firm, Marketbeat reports. Two research analysts have rated the stock with a sell recommendation, three have assigned a hold recommendation, two have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month target price among brokerages that have updated their coverage on the stock in the last year is $31.40.

PAHC has been the topic of several research analyst reports. Zacks Research upgraded shares of Phibro Animal Health from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, December 9th. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Phibro Animal Health in a research report on Monday, December 29th. Finally, JPMorgan Chase & Co. increased their target price on Phibro Animal Health from $45.00 to $50.00 and gave the stock an “overweight” rating in a research report on Friday, November 7th.

Insider Activity at Phibro Animal Health

In other news, CEO Jack Bendheim sold 5,752 shares of the company’s stock in a transaction dated Thursday, December 11th. The shares were sold at an average price of $40.93, for a total value of $235,429.36. Following the sale, the chief executive officer directly owned 39,200 shares of the company’s stock, valued at $1,604,456. This represents a 12.80% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In the last quarter, insiders have sold 146,882 shares of company stock worth $6,351,593. Insiders own 50.13% of the company’s stock.

Institutional Investors Weigh In On Phibro Animal Health

Several hedge funds have recently bought and sold shares of the business. Capricorn Fund Managers Ltd purchased a new stake in Phibro Animal Health during the 3rd quarter valued at about $10,233,000. Kings Path Partners LLC lifted its stake in shares of Phibro Animal Health by 87.3% in the second quarter. Kings Path Partners LLC now owns 20,600 shares of the company’s stock worth $526,000 after buying an additional 9,600 shares in the last quarter. Voya Investment Management LLC grew its holdings in shares of Phibro Animal Health by 44.3% during the first quarter. Voya Investment Management LLC now owns 31,894 shares of the company’s stock valued at $681,000 after buying an additional 9,796 shares during the last quarter. Allspring Global Investments Holdings LLC bought a new stake in shares of Phibro Animal Health during the third quarter valued at approximately $8,931,000. Finally, Trexquant Investment LP purchased a new position in Phibro Animal Health in the 1st quarter worth approximately $385,000. Institutional investors own 99.34% of the company’s stock.

Phibro Animal Health Price Performance

Shares of Phibro Animal Health stock opened at $39.72 on Friday. The business has a 50 day moving average of $40.89 and a 200 day moving average of $36.40. Phibro Animal Health has a 52 week low of $16.16 and a 52 week high of $46.42. The company has a market cap of $1.61 billion, a PE ratio of 23.93, a P/E/G ratio of 1.12 and a beta of 0.79. The company has a quick ratio of 1.35, a current ratio of 3.09 and a debt-to-equity ratio of 2.32.

Phibro Animal Health (NASDAQ:PAHC) last released its quarterly earnings results on Wednesday, November 5th. The company reported $0.73 earnings per share for the quarter, beating the consensus estimate of $0.58 by $0.15. Phibro Animal Health had a net margin of 4.85% and a return on equity of 36.26%. The business had revenue of $363.89 million for the quarter, compared to analysts’ expectations of $345.44 million. Phibro Animal Health has set its FY 2026 guidance at 2.640-2.810 EPS. As a group, equities research analysts forecast that Phibro Animal Health will post 1.95 earnings per share for the current year.

Phibro Animal Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, December 17th. Shareholders of record on Wednesday, November 26th were issued a $0.12 dividend. The ex-dividend date was Wednesday, November 26th. This represents a $0.48 dividend on an annualized basis and a yield of 1.2%. Phibro Animal Health’s dividend payout ratio is 28.92%.

About Phibro Animal Health

Phibro Animal Health Corporation (NASDAQ: PAHC) is a diversified global animal health and mineral nutrition company headquartered in Teaneck, New Jersey. The company develops, manufactures and markets a broad range of pharmaceutical, mineral nutrition and performance products designed to support the health and productivity of livestock, companion animals and aquaculture species. Phibro’s portfolio includes vaccines, anti-infective therapies, coccidiostats, disinfectants, premix minerals and specialty feed additives aimed at enhancing growth, immunity and overall animal well-being.

The company operates through three principal business segments: Animal Health, Mineral Nutrition and Performance Products.